Compare Kinder Morgan Inc (KMI) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinder Morgan Inc vs Mesoblast Limited — how do they compare? Kinder Morgan Inc trades at $31.46 (market cap $70.10B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Kinder Morgan Inc is far larger — about 31.7× Mesoblast Limited's market cap, and Kinder Morgan Inc pays a 3.75% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| KMI | MESO | |
|---|---|---|
Market Cap | $70.10B | $2.21B |
Sector | Energy | Technology |
52-Week High | $34.31 | $20.96 |
52-Week Low | $25.84 | $12.88 |
Enterprise Value | $102.15B | $2.21B |
Dividend Yield | 3.75% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
